Provided by Tiger Trade Technology Pte. Ltd.

Owens-Illinois

7.07
+0.05000.71%
Volume:2.84M
Turnover:20.35M
Market Cap:1.08B
PE:-0.94
High:7.30
Open:7.09
Low:6.95
Close:7.02
52wk High:16.91
52wk Low:6.29
Shares:153.28M
Float Shares:150.15M
Volume Ratio:1.11
T/O Rate:1.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.5405
EPS(LYR):-0.8401
ROE:-118.34%
ROA:3.57%
PB:2.83
PE(LYR):-8.42

Loading ...

O I Glass (OI) Invests In Muskogee Upgrade On A Fair Value Debate

Simply Wall St.
·
Yesterday

Ardagh Metal Packaging South America Names Rildo Lima CEO Effective Sept. 1, 2026

Reuters
·
Sep 01

Shiba Inu (SHIB) Forms Bull Flag: Can It Erase Zero Soon?

utoday
·
Sep 01

Aster and World Liberty Financial Launch USD1 RWA Boost: Phase 1, Offering 125M $WLFI + 6.25M USD1 in Rewards

utoday
·
Sep 01

XRP (XRPUSD) Is up 13.81% on Aug 22: Here Is Why

TradingKey
·
Aug 22

O-I Glass Price Target Raised to $9.00/Share from $8.00 by Citigroup

Dow Jones
·
Aug 22

O-I Glass Shares Rise After Citigroup Upgrade

MT Newswires Live
·
Aug 22

U.S. Stocks on the MOVE-Moderna, O-I Glass, Aveanna Healthcare

Reuters
·
Aug 22

O-I Glass Jumps After Citi Upgrades to 'buy' on Recovery Prospects

Reuters
·
Aug 21

Citigroup Upgrades O-I Glass to Buy From Neutral, Adjusts Price Target to $9 From $8

MT Newswires Live
·
Aug 21

O-I Glass Shares up 5.2% Premarket After Citigroup Raises to Buy from Neutral

THOMSON REUTERS
·
Aug 21

O-I Glass Inc : Citigroup Raises to Buy from Neutral; Raises Target Price to $9 from $8

THOMSON REUTERS
·
Aug 21

O-I Glass upgraded to Buy from Neutral at Citi

TIPRANKS
·
Aug 21

Crypto Lending Contracts by $11.3B in Q2 2026 as Market Embraces Orderly Deleveraging

Stock News
·
Aug 18

O-I Glass' Volume Outlook, Energy Headwinds Capping Growth, RBC Says

MT Newswires Live
·
Aug 13

RBC Downgrades O-I Glass to Sector Perform From Outperform, Adjusts PT to $8 From $10

MT Newswires Live
·
Aug 13

O-I Glass (OI) was downgraded to a Hold Rating at RBC Capital

TIPRANKS
·
Aug 13

Press Release: Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights

Dow Jones
·
Aug 11

Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)

GlobeNewswire
·
Aug 11

Shiba Inu: Shibarium Activity Surges 507% but Then Loses It All

utoday
·
Aug 11